Many of the people who are interested in vein treatment are also interested in investing in vein treatment stocks. Those are some smart people because stocks of certain treatment makers have risen considerably in the last year. Specifically, people have been investing in VNUS Medical Technologies, a company with stock values that unexpectedly soared late last year after the successful release of the VNUS Closure Fast system of varicose vein treatment.
Those people may have had some concerns this week after VNUS reported on its 2008 first quarter earnings. There was a decline in their stock value at that time. However, analysts who are talking about the business say that VNUS is expected to meet - if not exceed - their revenue projections for the 2008 and 2009 years. In other words, it's probably wise to keep hanging on to those stocks.
In terms of the medical community, this points to continued big plans by VNUS for providing quality varicse vein treatment over the course of the next few years. You're likely to see your own vein treatment doctor investing in the technology put out by this business (if he / she hasn't already). VNUS remains the company to watch.
Question of the Day: If you haven't already invested in VNUS stocks, are you thinking about doing so now or do you feel like they've peaked?
